Back
Akari Therapeutics PLC Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
10
AKTX
Akari Therapeutics PLC
Last Price:
1.28
Seasonality Move:
-8.33%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...Akari Therapeutics PLC Price Quote
$1.28
+0.04 (+-12.93%)
(Updated: November 22, 2024 at 3:54 AM ET)
Akari Therapeutics PLC Key Stats
Sell
10
Akari Therapeutics PLC (AKTX)
is a Sell
Day range:
$1.10 - $1.45
52-week range:
$1.08 - $4.40
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
177.4K
Avg. volume:
33.1K
1-year change:
-59.35%
Market cap:
$25.6M
Revenue:
$0
EPS:
$-2.75
How Much Does Akari Therapeutics PLC Make?
Data Unavailable
Is Akari Therapeutics PLC Growing As A Company?
Data Unavailable
Akari Therapeutics PLC Stock Price Performance
-
Did Akari Therapeutics PLC Stock Go Up Last Month?
Akari Therapeutics PLC share price went down by -42.59% last month -
Did AKTX's Share Price Rise Over The Last Year?
AKTX share price fell by -59.35% over the past 1 year
What Is Akari Therapeutics PLC 52-Week High & Low?
-
What Is Akari Therapeutics PLC’s 52-Week High Share Price?
Akari Therapeutics PLC has traded as high as $4.40 over the past 52 weeks -
What Is Akari Therapeutics PLC’s 52-Week Low Share Price?
Akari Therapeutics PLC has traded as low as $1.08 over the past 52 weeks
Akari Therapeutics PLC Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Akari Therapeutics PLC?
-
How Much Debt Does Akari Therapeutics PLC Have?
Total long term debt quarterly is $0 -
How Much Cash Does Akari Therapeutics PLC Have?
Cash and short term investments quarterly total is $2.2M -
What Is Akari Therapeutics PLC’s Book Value Per Share?
Book value per share is -0.55
Is Akari Therapeutics PLC Cash Flow Positive?
-
What Is AKTX Cash Flow From Operations?
Cash flow from operations (TTM) is -$14.8M -
What Is Akari Therapeutics PLC’s Cash Flow From Financing?
Cash flow from financing (TTM) is $12.4M -
What Is Akari Therapeutics PLC’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Akari Therapeutics PLC Return On Invested Capital
Data Unavailable
Akari Therapeutics PLC Earnings Date & Stock Price
-
What Is Akari Therapeutics PLC's Stock Price Today?
A single share of AKTX can be purchased today for 1.24 -
What Is Akari Therapeutics PLC’s Stock Symbol?
Akari Therapeutics PLC trades on the nasdaq under the ticker symbol: AKTX -
When Is Akari Therapeutics PLC’s Next Earnings Date?
The next quarterly earnings date for Akari Therapeutics PLC is scheduled on April 1, 2025 -
When Is AKTX's next ex-dividend date?
Akari Therapeutics PLC's next ex-dividend date is May 26, 2020 -
How To Buy Akari Therapeutics PLC Stock?
You can buy Akari Therapeutics PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Akari Therapeutics PLC Competitors
-
Who Are Akari Therapeutics PLC's Competitors?
Below is a list of companies who compete with Akari Therapeutics PLC or are related in some way:
Akari Therapeutics PLC Dividend Yield
-
What Is AKTX Dividend Yield?
Akari Therapeutics PLC’s dividend yield currently is 0% -
What Is Akari Therapeutics PLC’s Payout Ratio?
Akari Therapeutics PLC’s payout ratio is 0% -
When Did Akari Therapeutics PLC Last Pay A Dividend?
The latest dividend pay date is November 22, 2024 -
What Is Akari Therapeutics PLC’s Dividend Per Share?
Akari Therapeutics PLC pays a dividend of $0.00 per share
Akari Therapeutics PLC Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 100% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 80.00 |
| Upside from Last Price: | 6351.61% |